Monday, January 25, 2021
A Man Microdosed Dark Web Bought Mushrooms. This Is What Happened To His Organs.
Saturday, January 23, 2021
Tuesday, January 12, 2021
Bruce Willis kicked out of pharmacy for refusing to wear mask: Report
Sunday, January 10, 2021
Celebrities We Lost to Coronavirus in 2020
Thursday, January 7, 2021
Danger from COVID-19 Vaccine?
mRNA Vaccines Might Prove Catastrophic in a Rushed Coronavirus Response
Bombshell primer breaks down the very real risks of this cutting-edge technology
vaccines-might-prove- catastrophic-in-a-rushed- coronavirus-response/
Bobby Fischer | Mental Health & Personality
COVID 19 Vaccine (finally)
The FDA says Pfizer’s Covid vaccine is safe and effective. But trial participants warn of intense symptoms after second shot
Others experienced headaches and fatigue.
The FDA said that while side effects of the Pfizer vaccine are common, there are "no specific safety concerns identified that would preclude issuance of an EUA."
‘Star Wars’ Actor David Prowse Died From Covid-19
FDA panel endorses Pfizer coronavirus vaccine for emergency use | Fox Business
From what I can tell by casual observation, maybe 10 to 20% of the population doesn't want to take the vaccine.
All you need to know to understand 5G
"I CAN'T KEEP DOING THIS": Doctor pleads for review of data during COVID-19 Senate hearing
Ivermectin has antiviral effects against several distinct positive-sense single-strand RNA viruses, including SARS-CoV-2. On 10 April 2020, the FDA issued guidance to not use veterinary-grade ivermectin as treatment for COVID-19 in humans.
Ivermectin inhibits replication of SARS-CoV-2 in monkey kidney cell culture with an IC50 of 2.2 - 2.8 µM, making it a possible candidate for COVID-19 drug repurposing research. The doses used in cell culture would require 104 larger doses in humans based on this data, which does not look promising as an effective treatment for COVID-19. Such high doses of ivermectin are not covered by the current human-use approvals of the drug and could be dangerous, as the likely antiviral mechanism of action is the suppression of a host cellular process, specifically the inhibition of nuclear transport by importin α/β1.
A preprint published in April 2020 claimed benefits of ivermectin in the treatment of COVID-19, but it was a retrospective study based on questionable hospital data from Surgisphere and was withdrawn at the end of May. The preprint led to several government agencies in Latin America recommending ivermectin as a COVID-19 treatment; these recommendations were later denounced by the regional WHO office. On October 12, 2020 Peru withdrew its authorization to use ivermectin and hydroxychloroquine as COVID-19.
One study published on Dec. 2 in the International Journal of Infectious Diseases found that a five-day course of ivermectin was found to be safe and effective in treating mild COVID-19 adult patients. The trial involved 72 hospitalized patients in Bangladesh, and researchers said larger trials are needed to confirm the preliminary findings.
Another large study, published in November as a preprint, found the addition of ivermectin to standard care to be a "very effective drug for treatment of COVID-19 patients with significant reduction in mortality compared to hydroxychloroquine plus standard treatment only."